Press Release May 23 2025

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg".

View Attachment